MERIT MEDICAL SYSTEMS INC 10-Q

ITEM 5. OTHER INFORMATION On August 7, 2023 , F. Ann Millner, Ed.D ., one of our directors , adopted a trading arrangement for the sale of shares of our common stock (a “Rule 10b5-1 Trading Plan”) that is intended to satisfy the affirmative defense conditions of Exchange Act Rule 10b5-1(c). Dr. Millner’s Rule 10b5-1 Trading Plan, which has a term of two years , provides for sales of up to 66,250 shares of common stock pursuant to the terms of the plan. Other than with respect to Dr. Millner’s Rule 10b5-1 Trading Plan, none of our directors or officers informed us of the adoption or termination of a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as those terms are defined in Regulation S-K, Item 408 during the fiscal quarter ended September 30, 2023. ​ 41 Table of Contents ITEM 6. EXHIBITS Exhibit No. Description 3.1 ​ Second Amended and Restated Articles of Incorporation* 3.2 ​ Third Amended and Restated Bylaws* 31.1 ​ Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 31.2 ​ Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 32.1 ​ Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 32.2 ​ Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 101 ​ The following financial information from the quarterly report on Form 10-Q for the quarter ended September 30, 2023, formatted in Inline Extensible Business Reporting Language (iXBRL): (i) Consolidated Balance Sheets, (ii) Consolidated Statements of Income, (iii) Consolidated Statements of Comprehensive Income (iv) Consolidated Statements of Stockholders’ Equity, (v) Consolidated Statements of Cash Flows, and (vi) related Condensed Notes to the Unaudited Consolidated Financial Statements, tagged in detail. 104 Cover Page Interactive Data File (the cover page XBRL tags are embedded within the Inline XBRL document). ​ * These exhibits are incorporated herein by reference. † Indicates management contract or compensatory plan or arrangement. ​ ​ ​ 42 Table of Contents ​ SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. ​ ​ ​ ​ ​ MERIT MEDICAL SYSTEMS, INC. ​ ​ ​ Date: October 26, 2023 By: /s/ FRED P. LAMPROPOULOS ​ ​ Fred P. Lampropoulos, President and ​ ​ Chief Executive Officer ​ ​ ​ ​ Date: October 26, 2023 By: /s/ RAUL PARRA ​ ​ Raul Parra ​ ​ Chief Financial Officer and Treasurer ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ 43